Medicare Enrolled
Dr. Stephen Furs, M.D.
Gastroenterology · Cary, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Furs from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Furs?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Furs
Dr. Stephen Furs is a gastroenterology specialist in Cary, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Furs performed 908 Medicare services across 726 unique beneficiaries.
Between the years covered by Open Payments, Dr. Furs received a total of $4,616 from 44 pharmaceutical and/or device companies across 245 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Furs is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 26% volume in NC
$4,616 industry payments
Medicare Practice Summary
Medicare Utilization ↗908
Medicare services
Top 26% in NC for gastroenterology
726
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~48 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
296 | $51 | $180 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
121 | $166 | $728 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
103 | $79 | $200 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
69 | $171 | $675 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
68 | $50 | $145 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
64 | $69 | $557 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $102 | $275 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
27 | $113 | $677 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
21 | $4 | $20 |
| Hydrogen breath test A test that measures hydrogen levels in your breath to help evaluate stomach and bowel symptoms. |
20 | $56 | $120 |
| Dilation of esophagus | 19 | $28 | $350 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $79 | $180 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
13 | $172 | $675 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
12 | $48 | $120 |
| Rectal and anal tone and sensation test A physical examination to assess muscle tone and sensory function in the rectum and anus. |
12 | $364 | $825 |
| Rectal sensitivity and function study A test to evaluate the sensitivity and functional performance of the rectum. |
12 | $205 | $600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,616
Total received (2018-2024)
Avg $659/year across 7 years
Top 32% in NC for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
245
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,616 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,540
2023
$1,111
2022
$323
2021
$21
2020
$190
2019
$548
2018
$883
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$392
Janssen Biotech, Inc.
$165
QOL Medical, LLC
$134
Takeda Pharmaceuticals U.S.A., Inc.
$122
Lilly USA, LLC
$105
GENZYME CORPORATION
$70
Phathom Pharmaceuticals, Inc.
$61
Celgene Corporation
$60
Ardelyx, Inc.
$51
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$45
Medtronic, Inc.
$42
AIMMUNE THERAPEUTICS, INC.
$42
Boehringer Ingelheim Pharmaceuticals, Inc.
$35
SHIELD THERAPEUTICS INC
$22
Organon Llc
$22
Celltrion USA Inc.
$21
Fresenius Kabi USA, LLC
$20
IRONWOOD PHARMACEUTICALS, INC
$20
Regeneron Healthcare Solutions, Inc.
$18
Gilead Sciences, Inc.
$18
Intercept Pharmaceuticals, Inc.
$17
Ferring Pharmaceuticals Inc.
$17
Merck Sharp & Dohme LLC
$15
PFIZER INC.
$14
CapsoVision, Inc.
$13
Top 3 companies account for 44.9% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$763
AbbVie, Inc.
$686
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$415
Takeda Pharmaceuticals U.S.A., Inc.
$325
Janssen Biotech, Inc.
$314
QOL Medical, LLC
$204
Celgene Corporation
$201
Ferring Pharmaceuticals Inc.
$151
UCB, Inc.
$145
Ardelyx, Inc.
$112
Lilly USA, LLC
$105
Gilead Sciences, Inc.
$100
PFIZER INC.
$98
GENZYME CORPORATION
$91
Boehringer Ingelheim Pharmaceuticals, Inc.
$78
Phathom Pharmaceuticals, Inc.
$75
Daiichi Sankyo Inc.
$71
Regeneron Healthcare Solutions, Inc.
$61
Fresenius Kabi USA, LLC
$55
INTRA-SANA LABORATORIES
$50
Medtronic, Inc.
$42
AIMMUNE THERAPEUTICS, INC.
$42
Janssen Pharmaceuticals, Inc
$39
Organon LLC
$31
INTERCEPT PHARMACEUTICALS, INC.
$29
Boston Scientific Corporation
$23
Synergy Pharmaceuticals Inc
$23
SHIELD THERAPEUTICS INC
$22
Organon Llc
$22
Amgen Inc.
$21
Celltrion USA Inc.
$21
IRONWOOD PHARMACEUTICALS, INC
$20
AbbVie Inc.
$19
Pharmacosmos Therapeutics Inc.
$18
Intercept Pharmaceuticals, Inc.
$17
Blueprint Medicines Corporation
$16
Merck Sharp & Dohme LLC
$15
Novo Nordisk Inc
$15
Shield Therapeutics Inc
$15
Braintree Laboratories, Inc.
$14
Romark Laboratories, LC
$13
CapsoVision, Inc.
$13
Olympus America Inc.
$13
Ironwood Pharmaceuticals, Inc
$12
Top 3 companies account for 40.4% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AMJEVITA · Alinia Tablets 500mg 30 count bottle · Amitiza · CIMZIA · CLENPIQ · CREON · CYLTEZO · CapsoCam Plus · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · EOHILIA · Entyvio · GATTEX · HADLIMA · HUMIRA · Humira · IBSRELA · IDACIO · INJECTAFER · INTERSTIM · LINZESS · Linzess · MONOFERRIC · MOTEGRITY · OCALIVA · OMVOH · Olympus Tissue Acquisition Devices · Peripheral RotaLink Plus · REBYOTA · RELTONE 200 MG · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP · Saxenda · Sucraid · TREMFYA · TRULANCE · Trulance · UCERIS · VEGZELMA · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
108
Per 100K population
9.4
County median income
$101,763
Nearest hospital
WAKEMED, CARY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Furs is a clinical cardiology specialist, with above-average Medicare volume (top 26% in NC), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Furs experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Furs performed 296 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Furs receive payments from pharmaceutical companies?
Yes. Dr. Furs received a total of $4,616 from 44 companies across 245 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Furs's costs compare to other gastroenterologists in Cary?
Dr. Furs's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Furs) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Cary
Browse gastroenterologists in Cary ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in NC
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in NC
Which NC gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology